<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>DSpace Collection:</title>
    <link>http://localhost:8080/xmlui/handle/123456789/8035</link>
    <description />
    <pubDate>Thu, 09 Apr 2026 02:11:46 GMT</pubDate>
    <dc:date>2026-04-09T02:11:46Z</dc:date>
    <item>
      <title>Nephrotic Syndrome with Focal Segmental Glomerulosclerosis Histological Feature: A Case Report</title>
      <link>http://localhost:8080/xmlui/handle/123456789/9580</link>
      <description>Title: Nephrotic Syndrome with Focal Segmental Glomerulosclerosis Histological Feature: A Case Report
Authors: Samudra, Dian; Widodo, Widodo; Mardiana, Nunuk
Abstract: Introduction: Nephrotic syndrome is a clinical syndrome of heavy proteinuria and hypoalbuminemia or&#xD;
hypoproteinemia. Renal biopsy is fundamental to assess not only the type but also the degree of disease&#xD;
activity. The overall prognosis and response to treatment often depend on the severity of histological&#xD;
lesions and their reversibility.1,2 Case Presentation: An eighteen years old man with nephrotic syndrome&#xD;
and planned for a kidney biopsy. This case showed a patient with swollen face (especially on the cheek).&#xD;
On Biopsy results showing the glomerulus proliferation of cells and mesangeal matrix, adhesions in (50%)&#xD;
glomerulus, focal sclerosis in some glomeruli, erythrocyte cells visible in the urinary space and thickening&#xD;
of the basement membrane in some glomeruli, partially atrophic tubules, visible erythrocytes in the tubular&#xD;
lumen. Conclusion: An eighteen years old man with nephrotic syndrome with cushing syndrome and&#xD;
hypokalemia who had a renal biopsy. The histological feature from the renal biopsy was focal segmental&#xD;
glomerulosclerosis. The underlying cause of FSGS is still unclear. Assessing the diagnosis and etiology&#xD;
become important to direct the subsequent clinical approach and therapy&#xD;
Key words: Nephrotic syndrome, Focal segmental glomerulosclerosis, Renal biopsy</description>
      <pubDate>Sat, 01 Jan 2022 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://localhost:8080/xmlui/handle/123456789/9580</guid>
      <dc:date>2022-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Viral Meningoencephalitis Patient with Comorbid Major Depression with Psychotic Symptoms: A Case Report</title>
      <link>http://localhost:8080/xmlui/handle/123456789/9579</link>
      <description>Title: Viral Meningoencephalitis Patient with Comorbid Major Depression with Psychotic Symptoms: A Case Report
Authors: Farid Rizk, Maulana; Sugianto, Paulus; Maria Maramis, Margarita; Soetjipto, Soetjipto
Abstract: Viral meningoencephalitis causes meninges and brain parenchyma inflammation, thus provoking significant&#xD;
morbidity and mortality. Clinical features include neurological and psychiatric symptoms depending on&#xD;
the brain involved, mild symptoms such as fever, headache, neck stiffness, and confusion, or severe&#xD;
symptoms such as seizures, weakness, hallucinations, and coma. Therefore, the clinical diagnosis and&#xD;
treatment of such cases are challenging to make. This case report describes an adult male patient suffering&#xD;
from viral meningoencephalitis with comorbid major depression with psychotic symptoms. The patient&#xD;
requires holistic management of meningoencephalitis with comorbid depression and neuropsychiatric&#xD;
symptoms that may occur in the long term.&#xD;
Key words: Viral meningoencephalitis, Comorbid, Depression</description>
      <pubDate>Sat, 01 Jan 2022 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://localhost:8080/xmlui/handle/123456789/9579</guid>
      <dc:date>2022-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Massive Pleural Effusion with Adenosine Deaminase (ADA) Test Positive and COVID-19 Confirmed: A Case Report</title>
      <link>http://localhost:8080/xmlui/handle/123456789/9578</link>
      <description>Title: Massive Pleural Effusion with Adenosine Deaminase (ADA) Test Positive and COVID-19 Confirmed: A Case Report
Authors: Airene Novianti, Dewintha; Wardhani, Puspa
Abstract: A 26-year-old man complained of shortness of breath for 3 days before the hospital admission. The patient&#xD;
had a history of coughing up blood and had consumed alcohol and drugs. Decreased vesicular auscultation&#xD;
and dull percussion in the left lateral pulmo. Laboratory result showed increased neutrophil-lymphocyte&#xD;
ratio C-reactive protein, D-dimer, procalcitonin, ferritin, and decreased albumin level. Pleural fluid analysis&#xD;
indicated the presence of exudate, SARS-CoV-2 PCR positive, and increased ADA level to 43 U/L. Based on&#xD;
the examination results, we suspected that the etiology of the massive pleural effusion was tuberculous&#xD;
pleurisy, particularly due to increased ADA levels. The patient was diagnosed with COVID-19 pneumonia&#xD;
with massive pleural effusion and tuberculous pleurisy. Massive pleural effusion in SARS-CoV-2 infection&#xD;
is rare. Thus, laboratory modalities for massive pleural effusion diagnosis are needed to determine the&#xD;
etiology and effective treatment for the patient. ADA analysis could be considered as an initial examination&#xD;
in patients with pleural effusion during the wait for pleural fluid culture results.&#xD;
Key words: Pneumonia, COVID-19, Pleural effusion, Tb pleuritis, ADA test, Infectious disease</description>
      <pubDate>Sat, 01 Jan 2022 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://localhost:8080/xmlui/handle/123456789/9578</guid>
      <dc:date>2022-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Thalassemia β Major in Confirmed Covid-19 Patient: A Case Report</title>
      <link>http://localhost:8080/xmlui/handle/123456789/9577</link>
      <description>Title: Thalassemia β Major in Confirmed Covid-19 Patient: A Case Report
Authors: Butar Butar, Yosua; Wardhani, Puspa
Abstract: The incidence of Thalassemia with confirmed Covid 19 is very rare. The aim of this study is to know the&#xD;
prognosis and evaluate the management of therapy in thalassemia β Mayor patients with COVID-19.&#xD;
This case study describes the progression of Thalassemia β Mayor with COVID 19 starting from how to&#xD;
establish the diagnosis of Thalassemia β Mayor and COVID 19 until how to treat thalassemia β Mayor&#xD;
patients with COVID-19 This case study result describes that COVID 19 aggravates thalassemia β Mayor.&#xD;
Infection can adversely affect thalassemia. Giving Blood transfusions must be done due to anemia in&#xD;
Thalassemia, but it will have an impact on the accumulation of iron in the body which will increase the&#xD;
severity of the infection. The administration of iron-chelation drugs is beneficial for Covid but on the other&#xD;
hand, it is contraindicated in Thalassemia patients.&#xD;
Key words: Thalassemia, Infection, Preventable Death, COVID-19.</description>
      <pubDate>Sat, 01 Jan 2022 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://localhost:8080/xmlui/handle/123456789/9577</guid>
      <dc:date>2022-01-01T00:00:00Z</dc:date>
    </item>
  </channel>
</rss>

